EVMN

Insider trade Sale by Carver Kyle (Chief Financial Officer)

11h ago

SEC filing EVMN Posts $125M Private Placement, $19.3M Net Income, +94% YoY Revenue, EVO301 Phase 2a AD Data, EVO756 Phase 2b CSU/AD 2026 Reads

88d ago

SEC filing EVMN Announces $125M Private Placement, 4.5M Shares at $27.88

109d ago

News Evommune raises $125M privately

109d ago

News Evommune surges on mid-stage trial win for eczema therapy

111d ago

Scanner Unusual volume (z=7.5)

160d ago

Scanner Unusual volume (z=7.9)

161d ago

Scanner Unusual volume (z=7.9)

163d ago

Scanner Unusual volume (z=7.9)

164d ago